Blog - Page 3 of 23 - SourcePeptides.co Skip to content
Free Shipping On Every Order

Blog

Semax Peptide: The Definitive Research Guide (2026)

First synthesized in the Soviet Union as a derivative of adrenocorticotropic hormone, Semax has quietly accumulated one of the most intriguing preclinical research dossiers of any synthetic neuropeptide — spanning neurotrophin upregulation, cerebrovascular models, and cognitive task performance in rodents. This guide consolidates everything the scientific literature currently reveals about Semax, strictly in the context […]

Read more →

PT-141 Peptide Research Guide: Mechanisms, Melanocortin Biology & Nasal Spray vs Injectable Formats (2026)

PT-141, also known by its systematic name bremelanotide, is a synthetic cyclic heptapeptide that has attracted sustained preclinical research interest for its interactions with the melanocortin receptor system — particularly MC3R and MC4R subtypes in the central nervous system. Unlike many peptides studied for peripheral tissue effects, PT-141 research is distinguished by its CNS-centric mechanism, […]

Read more →

PT-141 Nasal Spray vs Injectable: Researcher’s Guide to Delivery Formats, Absorption Biology & Preclinical Study Comparisons (2026)

PT-141 (bremelanotide) is a synthetic cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone (α-MSH) that has attracted considerable attention in preclinical research for its activity at melanocortin receptors — particularly MC3R and MC4R. As interest in this compound grows within the research community, investigators are increasingly examining not just what PT-141 does at the receptor level, but […]

Read more →

BPC-157 Before and After: What Preclinical Research Reveals About Tissue, Recovery & Biological Outcomes Across Study Phases (2026)

BPC-157 before and after comparisons have become a central framework in preclinical peptide research, allowing investigators to systematically document biological changes across defined study intervals. BPC-157 — Body Protection Compound 157 — is a synthetic pentadecapeptide derived from a sequence found in human gastric juice, and its behavior in animal models has attracted sustained scientific […]

Read more →

BPC-157 Capsules vs Injectable: Researcher’s Guide to Oral vs Systemic Delivery, Bioavailability Biology & Preclinical Study Comparisons (2026)

BPC-157 capsules vs injectable formulations represent one of the most actively debated topics in peptide research circles, as scientists seek to understand how administration route influences the biological activity of this pentadecapeptide. BPC-157 — Body Protection Compound-157 — is a synthetic 15-amino-acid sequence originally derived from a gastric protein fraction, and its study across multiple […]

Read more →

Selank Peptide Research Guide: Mechanisms, Anxiolytic Biology & Preclinical Study Findings (2026)

Selank is a synthetic heptapeptide derived from the endogenous immunomodulatory tetrapeptide tuftsin, with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. First developed by the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank has attracted substantial scientific interest due to its interactions with the central nervous system, particularly in preclinical models examining anxiolytic-related mechanisms. Research into Selank […]

Read more →

KLOW Peptide Stack Research Guide: Mechanisms, Component Biology & Preclinical Study Findings (2026)

The KLOW peptide stack represents a multi-component research formulation combining several bioactive peptides into a single investigative platform. As interest in synergistic peptide combinations has expanded across preclinical research settings, KLOW has attracted attention for the breadth of biological systems its constituent peptides appear to engage. Understanding the individual mechanisms of each component — and […]

Read more →

BPC-157 and TB-500 Stack: Researcher’s Guide to Combined Mechanisms, Synergy & Preclinical Study Findings (2026)

The BPC-157 and TB-500 stack represents one of the most actively investigated peptide combinations in preclinical research, drawing significant interest from scientists studying tissue biology, angiogenesis, and extracellular matrix remodeling. BPC-157, a synthetic pentadecapeptide derived from a gastric protective protein, and TB-500, a thymosin beta-4 fragment, each operate through distinct but potentially complementary signaling pathways. […]

Read more →

CJC-1295 With DAC vs No DAC: Researcher’s Guide to Structural Differences, Release Kinetics & Preclinical Study Comparisons (2026)

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that has attracted sustained interest in peptide research circles due to its structural modifications over the native peptide sequence. Two primary variants exist in the research landscape: CJC-1295 with DAC (Drug Affinity Complex) and CJC-1295 without DAC (also referred to as Mod GRF 1-29). While […]

Read more →

MOTS-C vs SLU-PP-332: Metabolic & Exercise Research Compared (2026)

Among the most compelling areas of current peptide and small-molecule research is the intersection of mitochondrial biology, metabolic signaling, and exercise-related pathways. Two compounds that have attracted substantial preclinical interest in this space are MOTS-C — a mitochondria-derived peptide — and SLU-PP-332, a synthetic ERRα/γ agonist. While both have been studied in the context of […]

Read more →